GB2344590B - Attenuated poliovirus vaccine - Google Patents

Attenuated poliovirus vaccine

Info

Publication number
GB2344590B
GB2344590B GB9917024A GB9917024A GB2344590B GB 2344590 B GB2344590 B GB 2344590B GB 9917024 A GB9917024 A GB 9917024A GB 9917024 A GB9917024 A GB 9917024A GB 2344590 B GB2344590 B GB 2344590B
Authority
GB
United Kingdom
Prior art keywords
poliovirus vaccine
attenuated poliovirus
attenuated
vaccine
poliovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9917024A
Other versions
GB9917024D0 (en
GB2344590A (en
Inventor
Andrew Joseph Macadam
Philip David Minor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Publication of GB9917024D0 publication Critical patent/GB9917024D0/en
Publication of GB2344590A publication Critical patent/GB2344590A/en
Application granted granted Critical
Publication of GB2344590B publication Critical patent/GB2344590B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB9917024A 1998-08-06 1999-07-20 Attenuated poliovirus vaccine Expired - Fee Related GB2344590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9817082.2A GB9817082D0 (en) 1998-08-06 1998-08-06 Attenuated poliovirus vaccine

Publications (3)

Publication Number Publication Date
GB9917024D0 GB9917024D0 (en) 1999-09-22
GB2344590A GB2344590A (en) 2000-06-14
GB2344590B true GB2344590B (en) 2000-11-08

Family

ID=10836776

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9817082.2A Ceased GB9817082D0 (en) 1998-08-06 1998-08-06 Attenuated poliovirus vaccine
GB9917024A Expired - Fee Related GB2344590B (en) 1998-08-06 1999-07-20 Attenuated poliovirus vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9817082.2A Ceased GB9817082D0 (en) 1998-08-06 1998-08-06 Attenuated poliovirus vaccine

Country Status (2)

Country Link
GB (2) GB9817082D0 (en)
WO (1) WO2000007622A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0615933D0 (en) 2006-08-10 2006-09-20 Nat Inst Biological Standards & Control Attenuated polioviruses
JP5733976B2 (en) 2007-03-30 2015-06-10 ザ・リサーチ・ファウンデーション・フォー・ザ・ステート・ユニヴァーシティー・オブ・ニュー・ヨーク Attenuated viruses useful for vaccines
US8305914B2 (en) 2007-04-30 2012-11-06 Hewlett-Packard Development Company, L.P. Method for signal adjustment through latency control
GB201022077D0 (en) * 2010-12-29 2011-02-02 Health Prot Agency Inactivated poliovaccine
GB201700825D0 (en) * 2017-01-17 2017-03-01 Sec Dep For Health Poliovaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBO J Vol. 13 (4) 1994. Macadam A J et.al. pages 924-927 *
J. Biol. Chem. Vol. 272 (19) 1997. Barco A et.al. pages 12683-12691 *
J. Virology Vol. 69 (1) 1995. Shuyuarn F Y et.al. pages 247-252 *

Also Published As

Publication number Publication date
GB9917024D0 (en) 1999-09-22
GB9817082D0 (en) 1998-10-07
GB2344590A (en) 2000-06-14
WO2000007622A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
GB9711964D0 (en) Live attenuated vaccines
GB9812613D0 (en) Vaccine
GB9806456D0 (en) Vaccine composition
GB9823492D0 (en) Drape
IL137449A0 (en) Live vaccine against brucellosis
GB9822714D0 (en) Vaccines
HUP0104842A3 (en) Vaccine
GB2344590B (en) Attenuated poliovirus vaccine
GB9801870D0 (en) Vaccine composition
IL139269A0 (en) Hepatitis vaccine
GB9823835D0 (en) Component for vaccine
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9807805D0 (en) Vaccine
GB9805962D0 (en) Vaccine
GB9805960D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9806765D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9802543D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9805958D0 (en) Vaccine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20030720